40
Participants
Start Date
September 30, 2010
Primary Completion Date
December 31, 2010
Linagliptin/Metformin (standard batch)
Fixed dose combination tablet
Linagliptin/Metformin (side batch)
Fixed dose combination tablet
1288.6.1 Boehringer Ingelheim Investigational Site, Ingelheim
Lead Sponsor
Boehringer Ingelheim
INDUSTRY